13D/13G Filings - Cooperatieve AESCAP Venture I U.A.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-05-26
4:31 pm
Unchanged
2021-05-12 13D F-star Therapeutics, Inc.
FSTX
Cooperatieve AESCAP Venture I U.A. 615,643
3.100%
0
(Unchanged)
Filing
History
2021-02-09
5:00 pm
Purchase
2020-12-31 13G Orphazyme A/S
ORPHY
Cooperatieve AESCAP Venture I U.A. 1,758,105
5.100%
1,758,105increase
(New Position)
Filing
History
2020-12-03
5:08 pm
Purchase
2020-11-20 13D F-star Therapeutics, Inc.
FSTX
Cooperatieve AESCAP Venture I U.A. 615,643
6.800%
615,643increase
(New Position)
Filing
History